A warning about agranulocytosis with the use of cocaine adulterated with levamisole

Acta Clinica Belgica

Volumn 66, Issue 3, 2011, Pages 226-227

  Perkisas, S ^a   Vrelust, I ^a   Martin, M ^a   Gadisseur, A ^a   Schroyens, W ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Agranulocytosis; Cocaine; Levamisole

Indexed keywords

ANTIBIOTIC AGENT; COCAINE; LEVAMISOLE;

ADULT; AGRANULOCYTOSIS; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; FEMALE; FEVER; HUMAN; MASS SPECTROMETRY; MENINGITIS; PNEUMONIA; SEDIMENTATION RATE; SUBSTANCE ABUSE;

ADULT; AGRANULOCYTOSIS; ANTINEMATODAL AGENTS; COCAINE; COCAINE-RELATED DISORDERS; DRUG CONTAMINATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LEVAMISOLE;

EID: 79960991950     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.2143/ACB.66.3.2062553     Document Type: Article

References (5)

1. Zhu NY, LeGatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009; 150: 287-289.
2. Valentino AM, Fuentecilla K. Levamisole : an analytical profile. Microgram Journal 2005, volume 3, numbers 3-4.
3. Kouassi E, Caillé G, Léry L, Larivière, Vézina M. Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos. 1986; 7: 71-89. (Pubitemid 16155186)
4. Wilkinson P, Van Dyke C, Jatlow P. Intranasal & oral cocaine kinetics. Clin Pharm Therap 1980; 27: 386-394.
5. Wells, Jerry. "Summary report about Levamisole of the Committee for Veterinary Products". The European Agency for the Evaluation of Medicinal Products. 17/5/1996. http: //www.ema.europa.eu/pdfs/vet/mrls/levamisole2.pdf